GIP
IRMD icon

Granite Investment Partners’s iRadimed IRMD Stock Holding History

Granite Investment Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-35,633
Closed -$740K – 327
2018
Q2 		$740K Hold
35,633
– – 0.05% 184
2018
Q1 		$513K Sell
35,633
-63,605
-64% -$906K 0.03% 220
2017
Q4 		$1.5M Hold
99,238
– – 0.09% 166
2017
Q3 		$953K Sell
99,238
-13,024
-12% -$123K 0.06% 218
2017
Q2 		$965K Sell
112,262
-5,408
-5% -$46.2K 0.07% 235
2017
Q1 		$1.05M Sell
117,670
-4,408
-4% -$40.9K 0.07% 226
2016
Q4 		$1.35M Buy
+122,078
New +$1.31M 0.1% 201

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Granite Investment Partners's IRMD Position: Q3 2018 in Review

Granite Investment Partners sold out of iRadimed (IRMD) in Q3 2018, closing a stake of 35,633 shares — an estimated $740K sold.

Granite Investment Partners first reported a position in IRMD in Q4 2016 and held it in 7 quarters. The position peaked at $1.5M in Q4 2017. 68 funds tracked by Wall St. Rank hold IRMD as of Q3 2018.

  • Granite Investment Partners reported no remaining iRadimed position as of Q3 2018 after selling out during the quarter.
  • Granite Investment Partners sold 35,633 iRadimed shares in Q3 2018, an estimated $740K.
  • Granite Investment Partners first reported a position in iRadimed in Q4 2016 and held it in 7 quarters.
  • Granite Investment Partners's iRadimed position peaked at $1.5M in Q4 2017.
  • 68 funds tracked by Wall St. Rank held iRadimed as of Q3 2018.

Based on Granite Investment Partners's 13F filing for Q3 2018, filed 8 Nov 2018.